Acceptance of Postpartum Intrauterine Contraceptive Device as a Method of Contraception in a Tertiary Care Hospital, Karachi
Objective: To determine the acceptability of Post-Partum intra uterine contraceptive device, its safety and efficacy among the users.
Methodology: This observational prospective study was conducted in Jinnah Postgraduate Medical Centre, Karachi from January 2017 - July 2019. Non-probability consecutive sampling technique was used. After informed and written consent, patients who were fulfilling the inclusion criteria were included in our study and were counselled for various methods of modern contraception. Patients opting for postpartum intrauterine contraceptive device (PPIUCD) were followed. Data was entered and analyzed in SPSS 22. Continuous variables were reported using Mean±SD and categorical variables were reported in percentages.
Results: A total of 2960 women, 283 (9.5%) gave consent for PPIUCD. PPIUCD was inserted in 218 (7.3%) patients. Out of 218, 20 patients did not turn for follow up therefore removed from the study. Mean age of the patients was 27.1±4.3years (17-39years). Primigravida were 30 (15.2%) and 168 (84.8%) were multigravida. Acceptance was higher among gravida 2 (26%) and gravida 3 (25%). 126(63.6%) Patients had PPIUCD placed after normal vaginal delivery and 72(36.4%) patients had PPIUCD placed after cesarean section (emergency and elective). spontaneous expulsion of PPIUCD was reported by 6 patients but none of the patients wished for the removal of PPIUCD after its insertion. There were no cases of perforation. Infection after PPIUCD insertion was reported in 2 (1%) patients. 16 (8.1%) patients complained of heavy vaginal bleeding that resolved by taking mafenamic acid and tranexamic acid.
Conclusion: Postpartum insertion of intrauterine contraceptive device is an effective, safe, reversible, long acting contraceptive method.
Copyright (c) 2022 Journal of The Society of Obstetricians and Gynaecologists of Pakistan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.